SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607900. A total of 7 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,836,548 | +19.1% | 23,400 | +12.5% | 0.00% | +50.0% |
| Q2 2023 | $2,382,016 | -78.3% | 20,800 | -73.8% | 0.00% | -84.6% |
| Q1 2023 | $10,957,485 | +86.3% | 79,500 | +75.1% | 0.01% | +44.4% |
| Q4 2022 | $5,882,932 | +59.3% | 45,400 | +35.9% | 0.01% | +80.0% |
| Q3 2022 | $3,692,000 | +60.2% | 33,400 | +30.5% | 0.01% | +150.0% |
| Q4 2021 | $2,305,000 | -28.0% | 25,600 | -37.9% | 0.00% | -50.0% |
| Q2 2021 | $3,203,000 | -57.0% | 41,200 | -58.8% | 0.00% | -63.6% |
| Q1 2021 | $7,446,000 | +17.7% | 99,900 | +169.3% | 0.01% | +37.5% |
| Q4 2020 | $6,325,000 | +4.5% | 37,100 | -13.9% | 0.01% | -20.0% |
| Q3 2020 | $6,053,000 | +62.7% | 43,100 | +85.8% | 0.01% | +25.0% |
| Q2 2020 | $3,720,000 | +95.1% | 23,200 | +19.0% | 0.01% | +100.0% |
| Q1 2020 | $1,907,000 | -69.7% | 19,500 | -60.0% | 0.00% | -75.0% |
| Q4 2019 | $6,284,000 | +190.7% | 48,700 | +69.7% | 0.02% | +128.6% |
| Q3 2019 | $2,162,000 | -67.7% | 28,700 | -34.8% | 0.01% | -68.2% |
| Q2 2019 | $6,686,000 | +24.4% | 44,000 | -2.4% | 0.02% | +15.8% |
| Q1 2019 | $5,375,000 | – | 45,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 200,000 | $14,992,000 | 0.87% |
| GROUP ONE TRADING, L.P. | 276,500 | $20,726,000 | 0.03% |
| SG Americas Securities, LLC | 75,000 | $398,000 | 0.00% |
| JANE STREET GROUP, LLC | 101,000 | $7,571,000 | 0.00% |
| SIMPLEX TRADING, LLC | 25,700 | $1,926,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |